3,195 articles
On the occasion of International Data Privacy Day on 28/01/2015, Bosch, the global engineering and electronics major, invited Dr. Kalyan to deliver a lecture on privacy and its…
Bar & Bench interviewed Dr. Kalyan C. Kankanala on 26/01/2015 about his legal thriller “Pirates of Bollywood”, an IP-themed novel aimed at making intellectual property concepts accessible to…
This excerpt from Pirates of Bollywood presents a legal debate on copyright infringement involving technology platforms and indirect liability. The counsels discuss the balance between creative freedom and…
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects…
Weekly IP Warm-UP covers notable intellectual property law updates, including copyright and patent litigation, music industry developments, and trade secrets cases. The post analyses recent legal changes and…
The Charlie Hebdo attack in Paris in January 2015 left a lasting impact on the creative community, bringing attention to the risks faced by those championing free expression.…
The Indian Patent Office set aside Abbott Biotechnology's Humira patent after Glenmark's pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges…
The Indian music industry faces substantial revenue losses due to widespread digital piracy. Despite the growth in digital earnings, more than half of potential income is lost, suggesting…
An article published in the Indian Express on 11/01/2015, titled “More Spends on Patents Needed”, examined the comparatively low number of patents filed by Indian companies relative to…
RPX Corp. is acquiring around 4,000 patents from Apple’s Rockstar Consortium for US$ 900 million, effectively ending several major patent lawsuits. This deal highlights a move from litigation…
The UK Copyright Law now permits parodies and similar works under fair dealing, but judges decide if the work qualifies based on its humorous effect. This post analyses…
Astrazeneca has brought a patent infringement case against Aurobindo Pharma over an ANDA filing for Onglyza’s generic version in the US. The dispute centres on the alleged infringement…